|
MI usually due to occlusion of the |
coronary arteries |
|
The _____ is known as the natural pacemaker. |
SA node |
|
The SA node is located in the |
right atrium |
|
The AV node is located at the |
base of the right atrium |
|
The bundle branches carry the electrical signal to the |
ventricles |
|
The bundle branches end in the _____ fibers in the ventricles. |
Pukinje |
|
SA node causes the heart to beat _____-_____ bpm. |
60-100 |
|
AV node causes the heart to beat _____-_____ bpm. |
40-60 |
|
Ventricles cause the heart to beat <= _____ bpm. |
40 |
|
On an ECG, the firing of the SA node and depolarization of the atria correspond to the |
P wave |
|
On an ECG, the depolarization of the ventricles corresponds to the |
QRS complex |
|
On an ECG, repolarization of the ventricles corresponds to the |
T wave |
|
The cardiac cycle is composed of _____ and _____. |
systole, diastole |
|
Systole begins with closure of the _____ valves. |
AV |
|
Systole ends with closure of the _____ valves. |
semilunar |
|
During systole the _____ depolarize and contract to pump blood into the _____ and _____ circulation. |
ventricles, pulmonary, systemic |
|
Diastole begins with closure of the _____ valves. |
semilunar |
|
Diastole ends with closure of the _____ valves. |
AV |
|
During diastole the _____ repolarize and refill with blood. |
ventricles |
|
During atrial fibrillation, the _____ node fails to fire and something else in the atrium causes it to contract quickly. |
SA |
|
During atrial fibrillation, the heart rate is _____-_____ and always irregular (QRS complexes not evenly spaced). |
300-600 |
|
Atrial fibrillation puts the patient at risk for _____ because the blood doesnt leave the atrium and pools. |
clots |
|
Causes of atrial fibrillation include |
cardiac diseases, MI, CHF, cardiomyopathy, hyperthyroidism |
|
Can try to stop afib by _____ or use meds such as _____ and _____. |
defibrillate, Ca+ channel blockers, Coumadin |
|
During ventricular tachycardia (VTAC) the heart rate is _____-_____ bpm. |
100-250 |
|
VTAC is regular, has an abnormal rhythm, is either sustained or non-sustained, potentially lethal and can try to treat using _____ or with antidysrhythmics such as _____. |
defibrillation, Lidocaine |
|
Ventricular fibrillation is a _____ situation. |
code |
|
During ventricular fibrillation the ventricles are firing but not _____ (no organized method of firing in the heart). |
contracting |
|
A patient in VFIB has no _____, is usually _____, and not _____. |
pulse, unconscious, breathing |
|
Treat VFIB with meds and _____. |
CPR |
|
Asystole is when there is no or little electrical activity and is also called _____ _____. |
flat lining |
|
During asystole, defibrillation does or does not help. |
does not |
|
Normal BP is <_____ /><_____. |
120/80 |
|
Hypertension is defined as a BP consistently over _____/_____> but sometimes can be a single reading of >=180/110. |
140/90 |
|
Hypertensive complications include _____ and harmful to _____ (organ). |
strokes (CVA), kidneys (acute renal failure) |
|
Hypertension is more common _____-_____ years and in which ethnic group and sex. |
25-55, female African Americans |
|
BP is primarily regulated by _____ flow and _____ _____ resistance. |
blood, peripheral vascular |
|
BP is regulated by the _____ _____ system and the _____-_____ system. |
sympathetic nervous, renin-angiotensin |
|
_____ in produced in the _____ and plays a role in the conversion of angiotensin 1 to 2. |
renin, kidneys |
|
Angiotensin is a potent _____. |
vasoconstrictor |
|
The pituitary hormone ___ is also a vasoconstrictor. |
ADH |
|
_____ hypertension is does not have an underlying cause. |
primary |
|
_____ hypertension is does have an underlying cause. |
secondary |
|
Most cases (90-95%) of hypertension are _____. |
primary |
|
Contributing factors for primary hypertension are _____. |
incr sympathetic ns activity, obesity, sedentary lifestyle, high salt, high ETON, hormonal imbalances, diabetes, smoking, age/gender, heredity, hyperlipidemia, meds |
|
Hypertension is frequently asymptomatic but can present with what s/sx? |
fatigue, dyspnea, palpitations, angina, headache, nosebleeds, dizziness (in severe HTN) |
|
_____ is pain, discomfort, or pressure localized in the chest that is caused by an insufficient supply of blood (ischemia) to the heart muscle. |
angina |
|
Chronic hypertension left untreated can lead to _____. |
stroke, blood vessel damage (arteriosclerosis), MI or heart failure, kidney failure |
|
Untreated hypertension can lead to _____ _____ in which the walls of the hearts chambers thicken abnormally. |
Hypertrophic cardiomyopathy |
|
Additional lab work and tests for hypertension (by checking for systems damage) include _____. |
BUN, creatinine, UA, serum electrolytes, blood sugar, ECG |
|
Treatment for hypertension includes dietary approaches to stop hypertension (DASH), which is also an acronym for _____. |
dietary, activity, stress, hydration |
|
Medications for hypertension include _____ to reduce circulating blood volume. |
diuretics |
|
Medications for hypertension include _____ to reduce systemic vascular resistance (4). |
angiotensin inhibitors, calcium channel blockers, beta blockers, vasodilators |
|
_____ _____ = cardiac output x systemic vascular resistance. |
blood pressure |
|
Renin causes conversion of _____ to _____. |
angiotensin 1, 2 |
|
Angiotensin-converting enzyme (ACE) inhibitors block the conversion of _____ to _____. |
angiotensin 1, 2 |
|
Aldosterone is secreted by the adrenal cortex and causes increased _____ and _____ retention. |
sodium, water |
|
ACE inhibitors reduce _____ levels causing vasodilation. |
aldosterone |
|
ACE inhibitors are more effective in _____ than _____. |
Caucasian, African Americans |
|
ACE inhibitors increase _____ and lower ______. |
vasodilation, PVD |
|
ACE inhibitors all end in _____. |
pril (Lisinopril, Captopril) |
|
Contraindications for ACE inhibitors includes (3) |
hypersensitivity, renal artery stenosis, hyperkalemia (from aldosterone) |
|
Adverse effects for ACE inhibitors include (3) |
dry, hacking cough (ACE cough), first-dose syncope, hyperkalemia |
|
Considerations for ACE inhibitors include |
admin 1 hr before meals, no K+ salt substitutes, monitor labs (K+), BP before dose, change position slowly, not skip or stop abruptly, antacids 2 hrs before/after, pt report periph edema, infection, facial swelling, loss of taste, dyspnea |
|
ACE inhibitors are prone to damage from _____ and _____. |
heat, moisture |
|
_____-_____ is the resistance the left ventricle has to overcome to circulate blood. |
after-load |
|
Calcium Channel Blockers are a class IV _____. |
antiarrhythmic |
|
Calcium Channel Blockers inhibit ion influx into cells of _____ and _____ smooth muscle |
myocardial, arterial |
|
Calcium Channel Blockers dilate _____ arteries and _____. |
coronary, arterioles |
|
Calcium Channel Blockers increase _____ O2 delivery. |
myocardial |
|
Calcium Channel Blockers decrease _____-_____. |
after-load |
|
Calcium Channel Blockers uses include _____ and _____> |
hypertension, angina |
|
Calcium Channel Blockers meds include (4) |
amlodipine (Norvasc), diltiazem (Cardizem), nifedipine (Adalat), verapamil (Calan) |
|
Calcium Channel Blockers contraindications include (3) |
sick sinus syndrome w/o pacemaker, 2nd or 3rd degree heart blocks, severe hypotension |
|
Calcium Channel Blockers adverse effects include |
hypotension, peripheral edema, tachycardia, flushing, headache, constipation, increase digoxin levels |
|
Calcium Channel Blockers nursing considerations include |
monitor P and BP before admin (hold if <90 /><50 hold), change positions slowly, report weight gain, assess freq and charac of anginal attacks |
|
If the patient gains _____ lbs in one day or _____ lbs in one week they should notify physician due to volume overload. |
3, 5 |
|
Alpha 1 receptors found in _____ and alpha 2 receptors found in _____. |
periphery, CNS |
|
Beta 1 receptors found in _____ and beta 2 receptors found in _____. |
cardiac muscle, airways/lungs |
|
Beta blockers block beta-adrenergic receptors which decreases _____ _____, _____ _____, and _____. |
heart rate, blood pressure, contractility |
|
Blocking the _____ receptor decreases heart rate, myocardial O2 demands and contraction, and slows conduction through the AV node. |
Beta 1 |
|
Beta blockers uses include (4) |
hypertension, angina pectoris, acute myocardial infraction, supraventricular tachycardia (SVT) |
|
Beta blockers all end in _____ and include. |
lol, atenolol, metoprolol |
|
Contraindications for beta blockers include |
CHF, bradycardia, hypotension, heart block, bronchospasm |
|
Adverse effects for beta blockers include |
bradycardia, hypotension, worsening CHF, bronchospasm, impotence, dizziness, masks signs of hypoglycemia |
|
Nursing considerations for beta blockers include |
dont discontinue abruptly, hold if HR <60><90, change position slowly, protect extremities from cold, report ocular symptoms (can lower intraocular pressure), daily weight and I/O |
|
Alpha-Beta Blockers block selective alpha and beta receptors resulting in _____ and decreased _____, and reduced _____> |
vasodilation, PVR, BP |
|
Alpha-Beta Blockers also block beta receptors resulting in decreased _____ _____, _____ output, and _____ release from kidneys. |
heart rate, cardiac, renin |
|
Alpha-Beta Blockers used for (1) |
hypertension |
|
Alpha-Beta Blockers include |
labetalol, carvedilol (Coreg) |
|
Contraindications for Alpha-Beta Blockers include (4) |
severe bradycardia, heart block, asthma, uncontrolled CHF |
|
Adverse effects for Alpha-Beta Blockers include |
headache, dizziness, fainting, orthostatic hypotension, edema, weight gain, bronchospasm, explosive diarrhea (common) |
|
Nursing considerations for Alpha-Beta Blockers include |
VS, with food or after meal (incr absorb), I/O, report weight gain, prolonged standing, hot baths or weather, and strenuous exercise intensifies orthostatic hypotension |
|
Centrally-acting alpha-2 blockers (CAAs) stimulate alpha2 receptors which decreases sympathetic outflow (reduce epi, norepi) from the CNS brainstem to the (3) |
heart, kidneys, peripheral vessels |
|
CAAs result in a decrease in _____ and _____ and a reduced _____. |
PVR (vasodilation), CO, BP |
|
CAAs used for _____ but are not a first-line option. |
hypertension |
|
Common CAAs meds include |
methyldopa (Aldomet - causes daytime sedation), clonidine, guanabenz |
|
Contraindications for CAAs include |
hypersensitivity, active hepatic disease, pheochromocytoma, concurrent use of MAOIs, clonidine shouldnt be used with SLE |
|
Adverse effects for CAAs include |
nasal congestion, dry mouth, constipation, impotence, headache, dizziness, orthostatic hypotension, weight gain, rebound HTN |
|
Nursing considerations for CAAs include |
use cautiously older adults, orthostatic hypotension intensified with prolonged standing, hot baths/weather, strenuous exercise, and alcohol, avoid more than 4 cups of caffeinated bev per day, take at bedtime to avoid drowsiness, slowly wean off |
|
Alpha-1 blockers block stimulation of the SNS at the alpha-1 adrenergic receptor, which causes _____ and reduces _____. |
vasodilation, BP |
|
Alpha-1 blockers inhibit nor epinephrine reuptake by smooth muscle cells and reduces _____ and _____; this results in _____ and decreased _____ |
vasoconstriction, PVR; vasodilation, BP |
|
Alpha-1 blockers cause _____ and _____ retention, resulting in _____> |
sodium, water, edema |
|
Alpha-1 blockers usually take about _____ weeks to achieve therapeutic affect. |
2 |
|
Alpha-1 blockers meds all end in _____ and include. |
sin, prazosin, doxazosin |
|
Contraindications for Alpha-1 blockers include (1) |
hypersensitivity |
|
Adverse effects for Alpha-1 blockers include |
first-dose phenom, flushing, headache, dizziness, fainting, edema, tachycardia, palpitations |
|
Nursing considerations for Alpha-1 blockers include |
take w/food min GI distress, postural hypotension and palpitations usually disappear over time, avoid sudden changes position, avoid excessive caffeine, report weight gain or ankle edema |
|
Peripheral Adrenergic Antagonist block the exit of nor epinephrine, thereby inhibiting the activity of the _____ _____ _____. |
sympathetic nervous system |
|
Peripheral Adrenergic Antagonist uses include (1) |
hypertension |
|
Peripheral Adrenergic Antagonist meds include |
reserpine, guanadrel, guanethidine |
|
Contraindications for Peripheral Adrenergic Antagonist include (3) |
hypersensitivity, depression, pheochromocytoma |
|
Adverse effects for Peripheral Adrenergic Antagonist include |
SOB, fatigue, headache, drowsiness, orthostatic hypotension, predisposition to peptic ulcer disease |
|
Nursing considerations for Peripheral Adrenergic Antagonist include |
delayed effect, incr orthostatic risk with hot, prolonged, and exercise, monitor BP and HR, predisposes patient to depression |
|
Vasodilators are non-nitrate hypotensive agents that reduce _____ by direct effects on the vascular smooth muscles of _____ |
BP, arteries |
|
Vasodilators uses include (3) |
hypertension, adjunct for CHF, PVD (periph vascular disease) |
|
Vasodilators meds include |
hydralazine HCL (Alazine, Apresoline) |
|
Contraindications for Vasodilators include (2) |
inadequate cerebral perfusion, hypovolemia |
|
Adverse effects for Vasodilators include |
dizziness, hypotension, headache, palpitations, tachycardia, peripheral edema, orthostatic hypotension |
|
Nursing considerations for Vasodilators include |
monitor HR and BP before admin, take w/ food to incr absorption, wean off slowly to avoid paradoxical hypertensive effects, change position slowly, avoid hot tubs/baths |
|
Angiotensin II Inhibitors (Angiotensin Receptor Blockers - ARBs) block the vasoconstrictive and aldosterone-producing effects of Angiotensin II at receptor sites, causing _____ and lowered _____. |
vasodilation, BP |
|
Angiotensin II Inhibitors (Angiotensin Receptor Blockers - ARBs) uses are (1) |
hypertension |
|
Angiotensin II Inhibitors (Angiotensin Receptor Blockers - ARBs) meds all end in _____ and include |
-sartan, losartan (Cozaar), valsartan (Diovan) |
|
Contraindications for Angiotensin II Inhibitors (Angiotensin Receptor Blockers - ARBs) include (2) |
hypersensitivity, caution in renal/hepatic disease |
|
Adverse effect for Angiotensin II Inhibitors (Angiotensin Receptor Blockers - ARBs) include |
hypotension, dizziness, cough, gi upset, insomnia, tachy or bradycardia |
|
Nursing considerations for Angiotensin II Inhibitors (Angiotensin Receptor Blockers - ARBs) include |
VS, I/O, daily weights, K+ levels, dont discontinue abruptly, avoid salt substitutes, change position slowly |
|
Thiazide Diuretics increase diuresis by inhibiting _____ in the distal collecting tubules and on the proximal tubules of the kidney. |
sodium |
|
Thiazide Diuretics uses include (4) |
edema, hypertension, CHF, hepatic cirrhosis |
|
Thiazide Diuretics meds include |
hydrochlorothiazide, chlorothiazide, metolazone |
|
Contraindications for Thiazide Diuretics include |
hypersensitivity to sulfonamides, hypokalemia, anuria |
|
Adverse effects of Thiazide Diuretics include |
fluid/electrolyte imbalances, dry mouth, dizziness, impaired glucose tolerance, jaundice, muscle cramps, photosensitivity |
|
Nursing considerations for Thiazide Diuretics include |
VS, serum electrolytes, daily weights, I/O, dehydration, adequate tissue perfusion, weakness, muscle strength, restrict sodium intake, admin in morning or afternoon, change position slowly |
|
Loop diuretics inhibit _____ reabsorption in the ascending loop of Henle. This promotes the excretion of water and what 3 electrolytes? |
electrolyte, Na+, Cl-, K+ |
|
Uses for Loop diuretics include |
FVE for disorders of the heart, liver, kidney -- HTN, CHF, chronic renal failure, hepatic cirrhosis, edema, pulmonary edema |
|
Loop diuretics meds include |
furosemide (Lasix), bumetanide, torsemide, ethacrynic acid |
|
Contraindications for Loop diuretics include |
electrolyte depletion, anuria, digitalis, sulfonamide allergy |
|
Adverse effects for Loop diuretics include |
orthostatic hypo, ototoxicity (tinnitus, hearing loss), dizziness, hypo, headache, electrolyte imbalances |
|
Nursing considerations for Loop diuretics include |
VS, serum electrolytes, daily weights, I/O, dehydration, admin in am and afternoon, cautiously in elderly, eat food high in K+, change position slowly, incr photosensitivity, otto-toxicity (more from IV pushed too fast) |
|
Potassium-sparing act directly on distal convoluted tubule to incr _____ excretion and decrease _____ excretion. |
Na+, K+ |
|
Potassium-sparing uses include (2) |
hypertension, edema associated with heart failure |
|
Potassium-sparing meds include |
amiloride, spironolactone, triamterene |
|
Contraindications for Potassium-sparing include |
serum K+ levels > 5.5 mEq/mL, anuria, acute/chronic renal insufficiency, impaired hepatic function |
|
Adverse effects for Potassium-sparing (4) |
hyperkalemia, weakness/dizziness, headache, muscle cramps |
|
Nursing considerations for Potassium-sparing |
admin w/ food/milk, avoid salt sub, VS, UO, dehydration, lab values, excess K+ (nausea, diarrhea, abdominal cramps, tachycardia then bradycardia), can have photosensitivity |
|
Preload is the amount of blood in the _____ prior to _____. |
ventricles, contraction |
|
Afterload is the resistance to blood being ejected by the _____ |
left ventricle |
|
Cardiac output is _____ x _____. |
stroke volume, HR |
|
For a normal adult at rest, cardiac output is _____-_____ L/min. |
4-8 |
|
BP = _____x_____. |
CO, SVR |
|
SVR is the force opposing movement of blood and is created primarily in the small _____ and _____> |
arteries, arterioles |
|
Heart failure is defined as impaired |
cardiac pumping |
|
Risk factors for HF include |
advanced, age, CAD, HTN, diabetes, hyperlipidemia, smoking, obesity |
|
Right-sided heart failure is called _____ _____. |
cor pulmonale |
|
Right-sided heart failure leading cause is ______ and other causes include |
left-sided failure (also pulmonary disease), elevated pulmonary pressures, back up of blood into venous circulation |
|
Left-sided heart failure leading causes is _____ and other causes include |
left ventricular dysfunction assoc. w/ CAD & HTN, reduced left ventricular pumping, back up of blood into pulmonary vasculature |
|
Clinical manifestations of HF include |
dyspnea, orthopnea, tachypnea, crackles, cough (dry then productive), pink frothy sputum (PE), reduced UO, nocturia, weight gain, dependent edema, abdominal pain, anorexia, S3 & S4 heart sounds, chest pain |
|
Extra sound after S2 is |
S3 |
|
Blood going into the atria causes a soft sound before the first lub (S1) called |
S4 |
|
S__ and S__ are considered gallops. |
S3, S4 |
|
Diagnostic studies for HF |
chest x-ray, electrocardiogram, echocardiogram, hemodynamic monitoring, cardiac catheterization, serum BNP |
|
Serum BNP (brain natruretic peptide) responds to excessive stretching of the heart. Normal is <_____>_____ means patient has some HF. |
100, 500 |
|
Physical assessment findings for HF include |
wt gain, edema, crackles, JVD, dyspnea, tachypnea, decr O2 sats, cool, pale, diaphoretic skin, S3/S4, tachycardia, abdominal distention, liver engorgement, restless, confused |
|
S1 is the closure of the _____ and _____ valves. |
mitral, tricuspid |
|
Time between S1 and S2 is |
systole |
|
Best way to diagnose JVD is with the bed at _____ angle. |
45, high fowlers |
|
Treat HF using Unload Fast which stands for |
Upright position, Nitrates, Lasix, O2, ACE inhibitors, Digoxin, Fluids (decr), Afterload (decr), Sodium restriction, Testing (dig level, ABGs, K+ level) |
|
Care for patient with HF by decreasing _____ volume, decreasing _____ return (preload), decreasing _____load, improving _____ exchange, and improving _____ function. |
intravascular, venous, afterload, gas, cardiac |
|
For HF, decrease intravascular volume using |
diuretics (loop: Lasix, Bumex), fluid restriction, sodium restriction |
|
For HF, decrease venous return (preload) by |
elevate HOB, feed dependant, vasodilators (nitroglycerine) |
|
For HF, decrease afterload using _____ to reduce SVR. |
vasodilators |
|
For HF, improve gas exchange using |
supplemental O2, morphine |
|
For HF, improve cardiac function by |
increasing cardiac contractility (digitalis), reducing cardiac demands (rest) |
|
HF meds |
digitalis, ACE inhibitors (angiotensin converting enzyme), ARBs (angiotensin II receptor blockers, diuretics, beta blockers, vasodilators, morphine |
|
A med, such as digitalis, increases muscular contraction and is known as |
inotropic |
|
A med, such as ACE inhibitors, are vasodilators, slow the heart and are known as |
chronotropic |
|
A med that decreases conduction of heart cells (decr electrical activity) are know as |
dromotropic |
|
This med decreases fluid overload and ECF. |
diuretic |
|
This med decreases venous blood return to the heart and decreases cardiac filling (decreases preload). |
vasodilators |
|
This type of med is usually contraindicated in person with HF because they decrease cardiac contractility. |
beta blockers |
|
When treating HF using diuretics, you usually start with _____ diuretics but may also use _____ and _____ sparing diuretics. |
Thiazide, loop, K+ |
|
Digoxin and digitoxin are cardiac glycosides. They increase contractility and efficiency of myocardial contraction (+inotropic), slow HR (-chronotropic), decrease SA/AV node conduction (dromotropic) and are used for _____ and atrial _____. |
HF, atrial dysrhythmias (atrial fib, atrial flutter, paroxysmal atrial tachycardia) |
|
Symptoms of digitoxicity include |
heart not beating right or racing, anorexic, hyperkalemic, n/v/d, visual disturbances (yellow, halos) |
|
Of digoxin and digitoxin, one has 1/2 life of 36 hours and one has 1/2 life of 4-9 days. |
digoxin (36), digitoxin (4-9) |
|
Antidote for digoxin is _____. It binds with digoxin and enables it to be excreted. |
digoxin immune FAB (Digibind) |
|
Contraindications for cardiac glycosides (digoxin) include |
hypersensitivity, digitoxicity, renal insufficiency, hypokalemia, acute MI, heart block (impulse between atria and ventricles not in sync) |
|
Adverse effects for cardiac glycosides (digoxin) include |
headache, n/v, loss of usual appetite, toxic effect (anorexia, visual disturbances (blurred, green, yellow, halos)) |
|
Nursing considerations for cardiac glycosides (digoxin) include |
mon digoxin serum levels, toxicity, assess apical pulse, eat foods high in K+, daily weights, I/O |
|
Normal therapeutic levels of digoxin are 0._ - _ ng/ml. |
0.8 - 2 |
|
A level >_____ng/ml of digoxin is considered toxic. |
2 |
|
When giving digoxin, you should monitor the apical pulse for 1 minute before giving. If <_____>_____ bpm, do not give it. |
60, 120 |
|
Decreased oxygen-rich blood to an area which can cause pain and dysfunction is called |
ischemia |
|
PVD more commonly affects people _____-_____ years old. |
60-80 |
|
Risk factors for PVD include |
smoking, hyperlipidemia, diabetes, HTN |
|
Clinical manifestations of PAD in lower extremities includes |
intermittent claudication, paresthesia, reduced peripheral pulses, atrophy of muscle and skin, absence of hair, ulcerations leading to gangrene, cool, pale to cyanotic, dependant rubor (redness) |
|
Diagnostic studies for PAD |
Doppler, angiography, ankle brachial index |
|
Treatment for PAD |
angioplasty, stent, atherectomy (remove plaque, bypass, endarterectomy (roto-rooter), meds, exercise, diet, lifestyle |
|
Care of patient post revascularization procedure include |
peripheral pulses, skin color, temp, sensation, bleeding, hematoma, thrombosis, early ambulation, avoid knee flexed and extended sitting |
|
Collaborative care for chronic venous insufficiency |
compression, elevation of extremities, antibiotics, wound care, skin grafts |
|
Risk factors for DVT |
venous stasis (slow blood flow), endothelial damage, hypercoagulability |
|
DVT clinical manifestations |
unilateral leg edema, pain, warm skin, erythema |
|
Prevent DVT by |
early ambulation, leg exercises, prophylactic anticoagulants, ICDs, compression stockings |
|
Treat DVT by |
bed rest (bathroom privileges), anticoagulants, No ICDs or compression stockings, elevation of extremity, warm moist heat, avoid Valsalva maneuvers |
|
No ambulation or compression once DVT is present because it might |
dislodge embolism |
|
PE clinical manifestations |
chest pain, dyspnea, incr respiratory rate, decr O2 sat, cyanosis |
|
PE diagnostic studies |
perfusion scanning, ventilation scanning, d-dimer (serum blood test to measure clots that have broken up) |
|
Coumadin prevents conversion of vitamin _____, which reduces several clotting factors and delays blood coagulation |
K |
|
Uses for Coumadin |
DVT, PE, acute MI, heart valve replacement, atrial fibrillation, antiphospholipid syndrome |
|
Contraindications for Coumadin |
pregnancy, hemorrhage, malignant hypertension, liver failure |
|
Adverse effects for Coumadin |
bleeding, ecchymosis, n/d, abdominal cramping, hypotension, thrombocytopenia |
|
Antidote for Coumadin is |
vitamin K |
|
Nursing considerations for Coumadin |
slow onset, monitor baseline labs (PT, INR), lasts from several months to life long, minimize foods high in vitamin K (green leafy veg) |
|
Coumadin often takes _____ days to get to therapeutic levels. |
3-4 or up to 1 week |
|
Check Coumadin levels using which test |
INR (2-3 or 3-4.5 (mechanical heart valve replacement)) |
|
Heparin combines with the plasma heparin cofactor _____ and this inactivates specific clotting factors. |
antithrombin III |
|
Heparin uses |
DVT, PE, embolism from atrial flutter, prophylactic trt for at risk for thrombi development, used to flush vascular access devices |
|
Contraindications for Heparin |
uncontrolled bleeding, thrombocytopenia, avoid concurrent w/ ASA, NSAIDs |
|
Adverse effects for Heparin |
heparin-induced thrombocytopenia, longer duration incr risk for osteoporosis |
|
Nursing considerations for Heparin |
monitor baseline labs, subQ admin, monitor for bleeding (Hemoccult all stools), verify dose with another RN, educate to monitor for bleeding, antidote is protamine sulfate |
|
Check Heparin levels using which test |
aPTT |
|
Antidote for Heparin is |
protamine sulfate |
|
Antiplatelet agent uses |
thrombus formation (hx of MI, stroke, cardiac surgery) |
|
Antiplatelet agent meds |
aspirin, ticlopidine (Ticlid), clopidogrel bisulfate (Plavix), dipyridamole (Persantine) |
|
Contraindications for antiplatelet agents |
hypersensitivity, bleeding disorders, asthma, pregnancy, peptic ulcer disease |
|
Adverse effects for Antiplatelet agents |
GI symptoms, increased bleeding, bruising, n/v |
|
Nursing considerations for antiplatelet agents |
baseline hema labs, VS, mon bleeding time, stopped 7 days before planned surgery, assess for ASA toxicity (tinnitus & ototoxicity) |
|
Coronary artery disease is |
endothelial injury, inflammatory response, accumulation of lipids in vessel wall, growth of smooth muscle over lipid plaque, plaques can rupture, accum of platelets leads to thrombosis |
|
Non-modifiable risk factors for CAD |
age, family history, sex (males, females after menopause) |
|
Modifiable risk factors for CAD |
smoking, blood sugar, HTN, obesity, Type A, inactivity, hyperlipidemia (increased LDL, decreased HDL) |
|
LDL transport cholesterol from _____ to cells |
liver |
|
HDL transport cholesterol from _____ to liver where they are broken down. |
cells |
|
Increased LDL levels associated with |
diabetes, genetics, excessive ETOH, obesity, inactivity, high fat diet, smoking |
|
Cholesterol should be <_____ |
200 |
|
Triglyceride should be <_____ |
190-200 |
|
LDL levels should be <_____ />_____ mg/dL is a high risk. |
130, 160 |
|
HDL levels should be >_____ mg/dL and if <_____ mg/dL is a high risk. |
60, 40 (men) or 50 (women) - increases risk of CAD |
|
Reduce blood lipids via meds and lifestyle changes such as |
low saturated fats, high fiber, substitute soy based for animal proteins, fatty fish or Omega-3, weight reduction, exercise, quit smoking |
|
Antilipidemics include |
statins, Zetia, Questran, niacin (B3) |
|
Statins include |
Simvastatin (Zocor), lovastatin (Mevacor), atorvastatin (Lipitor) |
|
Side effects of statins |
muscle pain, SE rhabdomyolysis (flu like symptoms, tenderness, weakness), myopathy, strain on kidneys |
|
Lab test to assess if muscle breakdown is occurring |
myoglobin |
|
Antilipidemics interactions |
may increase effects of oral anticoagulants, combo of antilipidemics may increase risk of rhabdomyolysis |
|
Nursing implications for statins |
mon serum cholesterol, triglycerides, liver enzymes, follow diet, abd. Pain, d/n/v, take with evening meal or at bedtime, preg cat X, do not stop abruptly (MI or death) |
|
Niacin uses |
pellagra, hyperlipidemia, PVD that presents risk for pancreatitis |
|
To get cholesterol lowering effect need large doses of Niacin of _____-_____ grams/day` |
1.5-6 |
|
Niacin interactions |
postural hypotension (ganglionic blockers), flushing, pruritus (avoid using with ETOH), myopathy, rhabdomyolysis (HMG-CoA reductase inhibitors) |
|
Contraindications for Niacin |
hypersensitivity, hepatic disease, peptic ulcer, hemorrhage, severe hypotension, lactation |
|
Side effects of Niacin |
postural hypotension, dizziness, blurred vision, n/v/d, dry skin, rash, itching |
|
Nursing implications for Niacin |
mon lipid, triglyc, choles, hepatic studies (AST, ALT, etc.), glucose, cardiac status, hepatic dysfunction (clay-colored stools, dark urine, jaundice), headache, paresthesias, n/v/d, anemia, confusion |
|
Patient teaching for Niacin |
flushing/feelings of warmth for several hours after taking (81-325 mg ASA to reduce flushing), no alcohol, avoid sunlight if skin lesions present, clay-colored stools, anorexia, jaundice, dark urine, GI upset |
|
Angina is chest pain due to myocardial _____ |
ischemia |
|
Angina due to myocardial ischemia is reversible or not reversible? |
reversible |
|
Clinical manifestations of Angina |
pressure, squeezing, suffocation, SOB, may radiate to neck, jaw, arms, shoulders, may be silent, may be accompanied by cool diaphoresis, anxiety, impending doom, weakness |
|
Three types of angina - chronic _____ angina, _____ angina, _____ angina |
stable, unstable, vasospastic |
|
Chronic stable angina caused by atherosclerosis, ischemic heart disease and triggered by exertion, smoke, caffeine, ETOH and _____ w/in 15 min of rest or med |
subsides |
|
Unstable angina is an early stage of _____ and can progress to MI. |
CAD |
|
Nursing interventions for chest pain rt to myocardial ischemia |
rest, O2, 12 lead EKG, assess pain, VS, meds, cardiac markers |
|
Diagnostic tests for angina |
ekg, chest x-ray, lab tests (troponin, CK-MB (creatine kinase), C reactive protein |
|
Meds used for angina and acute coronary syndrome |
antiplatelet, nitroglycerine, B-adrenergic blockers, Ca+ channel blockers, thrombolytics, ACE inhibitors, antiarrhythmic drugs |
|
Antianginal meds - 3 main classes |
nitrates/nitrites, beta-blockers, Ca+ channel blockers |
|
Overall goal of antianginal meds |
increase blood flow and/or decrease O2 demand |
|
Antianginal meds - 3 main therapeutic roles (objectives) |
decrease freq and duration/intensity of angina, improve functional capacity, prevent/delay MI |
|
Nitrates increase blood flow to myocardium, dilate venous system, reduce myocardial O2 demands and uses include |
prophylactic trt of angina in patients with CAD, acute chest pain |
|
Common Nitrates include |
nitroglycerin (SL, SR, topical, transdermal), isosorbide dinitrate (Isordil), isosorbide (Imdur, Monoket) |
|
Contraindications for Nitrates |
hypersensitivity, severe anemia, head trauma, cerebral hemorrhage, cardiomyopathy, use of ED drugs within 24 hrs. |
|
Adverse effects of Nitrates |
headache (50%), flushing, hypotension, rash, local burning/tingling, GI upset with PO, contact dermatitis |
|
Nursing considerations for Nitroglycerin |
sit next to phone when taking SL NTG tablets, no more than 3 (1 every 5 min), wear gloves when applying paste, rotate location if patch, mon BP and HR, orthostatic hypotension, change position slowly |





Review All
Quiz!


